Funding
Supported by the Fundamental Research Funds for the Central
Universities(Grant no.
2019jbkyzy002,lzujbky-2019-ct02,2020jbkyzx001,lzujbky-2020-kb20)
Fig.1 Flow diagram;
Fig.2a, b Risk of bias
Fig.3 Association between various
phytoestrogens with the effectiveness of depression.
e-Fig
1. The result of sensitivity analysis
e-Fig.2 The trim and -fill funnel plot.
e-Fig.3 Association between isoflavone and lignans groups with the
effectiveness of menopausal women to remission depression in different
evaluation scales
e-Fig.4 Association between three intake doses’ group with the
effectiveness of menopausal women to remission depression.
e-Fig. 5 Association between various scales with the effectiveness of
menopausal women to remission depression.
e-Fig.6 Association between isoflavone and lignans groups with the
effectiveness of menopausal women to remission depression in different
evaluation scales except for KMI and GCS scales.
e-Fig.7 Association between three intake doses ’groups with the
effectiveness of menopausal women to remission depression in different
evaluation scales except for KMI and GCS scales.
e-Fig.8 Association between eight countries with the effectiveness of
menopausal women to remission depression.
Table1. Characteristic of the studies included in the meta-analysis
Table2. The adverse events in all included studies
Reference
1. Glisic M, Kastrati N, Musa J, et al. Phytoestrogen supplementation
and body composition in postmenopausal women: A systematic review and
meta-analysis of randomized controlled trials. Maturitas.2018;115:74-83.
2. Aghamiri V, Mirghafourvand M, Mohammad-Alizadeh-Charandabi S,
Nazemiyeh H. The effect of Hop (Humulus lupulus L.) on early menopausal
symptoms and hot flashes: A randomized placebo-controlled trial.Complement Ther Clin Pract. 2016;23:130-135.
3. Gerbarg PL, Brown RP. Pause menopause with Rhodiola rosea, a natural
selective estrogen receptor modulator. Phytomedicine :
international journal of phytotherapy and phytopharmacology.2016;23(7):763-769.
4. Hale G, Bievre M, Hughes C. Exploring the role of progestins and
phytoestrogens in menopause. Integrative Medicine.1999;2(2-3):133-141.
5. Llaneza P, García-Portilla MP, Llaneza-Suárez D, Armott B,
Pérez-López FR. Depressive disorders and the menopause transition.Maturitas. 2012;71(2):120-130.
6. Perez-Lopez FR, Perez-Roncero G, Fernandez-Inarrea J, et al.
Resilience, depressed mood, and menopausal symptoms in postmenopausal
women. Menopause (New York, NY). 2014;21(2):159-164.
7. Johnston E, Johnson S, McLeod P, Johnston M. The relation of body
mass index to depressive symptoms. Canadian journal of public
health = Revue canadienne de sante publique. 2004;95(3):179-183.
8. Lee JY, Park YK, Cho KH, et al. Suicidal ideation among
postmenopausal women on hormone replacement therapy: The Korean National
Health and Nutrition Examination Survey (KNHANES V) from 2010 to 2012.Journal of affective disorders. 2016;189:214-219.
9. Birkhäuser M. Menopause, oestrogen deficiency and depression.Archives of Women’s Mental Health. 2011;14:S97.
10. Faubion SS, Litin SC, Bundrick JB. Clinical Pearls in women’s
health. Disease-a-Month. 2017;63(6):149-157.
11. Finnell JE, Lombard CM, Moffitt CM, et al. The role of estradiol on
social stress induced depressive-like behavior and neuroinflammation in
females. FASEB Journal. 2017;31(1).
12. Al-Safi ZA, Santoro N. Menopausal hormone therapy and menopausal
symptoms. Fertility and Sterility. 2014;101(4):905-915.
13. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M.
Lack of efficacy of estradiol for depression in postmenopausal women: a
randomized, controlled trial. Biol Psychiatry.2004;55(4):406-412.
14. Bai F, Ling J, Esoimeme G, et al. A systematic review of
questionnaires about patient’s values and preferences in clinical
practice guidelines. Patient preference and adherence.2018;12:2309-2323.
15. Lee HW, Jun JH, Kil KJ, Ko BS, Lee CH, Lee MS. Herbal medicine
(Danggui Shaoyao San) for treating primary dysmenorrhea: A systematic
review and meta-analysis of randomized controlled trials.Maturitas. 2016;85:19-26.
16. Atteritano M, Mazzaferro S, Bitto A, et al. Genistein effects on
quality of life and depression symptoms in osteopenic postmenopausal
women: a 2-year randomized, double-blind, controlled study.Osteoporosis international. 2014;25(3):1123‐1129.
17. Power KA, Thompson LU. Can the combination of flaxseed and its
lignans with soy and its isoflavones reduce the growth stimulatory
effect of soy and its isoflavones on established breast cancer?Molecular nutrition & food research. 2007;51(7):845-856.
18. Lipovac M, Chedraui P, Gruenhut C, Gocan A, Stammler M, Imhof M.
Improvement of postmenopausal depressive and anxiety symptoms after
treatment with isoflavones derived from red clover extracts.Maturitas. 2010;65(3):258-261.
19. Keshavarz Z, Golezar S, Hajifoghaha M, Alizadeh S. The effect of
phytoestrogens on menopause symptoms: A systematic review. Journal
of Isfahan Medical School. 2018;36(477):446-459.
20. de Sousa-Muñoz RL, Filizola RG. Efficacy of soy isoflavones for
depressive symptoms of the climacteric syndrome. Maturitas.2009;63(1):89-93.
21. Su BYW, Tung TH, Chien WH. Effects of phytoestrogens on depressive
symptoms in climacteric women: A meta-analysis of randomized controlled
trials. Journal of Alternative and Complementary Medicine.2018;24(8):850-851.
22. Norris SL, Meerpohl JJ, Akl EA, et al. The skills and experience of
GRADE methodologists can be assessed with a simple tool. J Clin
Epidemiol. 2016;79:150-158 e151.
23. Chen Y, Yang K, Marusic A, et al. A Reporting Tool for Practice
Guidelines in Health Care: The RIGHT Statement. Ann Intern Med.2017;166(2):128-132.
24. Ge L, Tian JH, Li YN, et al. Association between prospective
registration and overall reporting and methodological quality of
systematic reviews: a meta-epidemiological study. J Clin
Epidemiol. 2018;93:45-55.
25. Higgins JP, Thompson SG. Quantifying heterogeneity in a
meta-analysis. Statistics in medicine. 2002;21(11):1539-1558.
26. Xiu-xia L, Ya Z, Yao-long C, Ke-hu Y, Zong-jiu Z. The reporting
characteristics and methodological quality of Cochrane reviews about
health policy research. Health Policy. 2015;119(4):503-510.
27. Flemyng E, Dwan K, Moore TH, Page MJ, Higgins JP. Risk of Bias 2 in
Cochrane Reviews: a phased approach for the introduction of new
methodology. The Cochrane database of systematic reviews.2020;10:Ed000148.
28. Rosenthal R. The ”File Drawer Problem” and Tolerance for Null
Results. Psychological Bulletin. 1979;86(3):638-641.
29. Page MJ, Sterne JAC, Higgins JPT, Egger M. Investigating and dealing
with publication bias and other reporting biases in meta-analyses of
health research: A review. Research synthesis methods. 2020.
30. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method
of testing and adjusting for publication bias in meta-analysis.Biometrics. 2000;56(2):455-463.
31. Cheung M, Ho R, Lim Y, Mak A. Conducting a meta-analysis: basics and
good practices. International journal of rheumatic diseases.2012;15(2):129-135.
32. Ishiwata N, Melby MK, Mizuno S, Watanabe S. New equol supplement for
relieving menopausal symptoms: randomized, placebo-controlled trial of
Japanese women. Menopause (New York, NY). 2009;16(1):141-148.
33. Hirose A, Terauchi M, Akiyoshi M, Owa Y, Kato K, Kubota T. Low-dose
isoflavone aglycone alleviates psychological symptoms of menopause in
Japanese women: a randomized, double-blind, placebo-controlled study.Archives of Gynecology and Obstetrics. 2016;293(3):609-615.
34. Park JY, Kim KH. A randomized, double-blind, placebo-controlled
trial of Schisandra chinensis for menopausal symptoms. Climacteric
: the journal of the International Menopause Society.2016;19(6):574-580.
35. Shamshad Begum S, Jayalakshmi HK, Vidyavathi HG, et al. A Novel
Extract of Fenugreek Husk (FenuSMART™) Alleviates Postmenopausal
Symptoms and Helps to Establish the Hormonal Balance: A Randomized,
Double-Blind, Placebo-Controlled Study. Phytotherapy Research.2016;30(11):1775-1784.
36. Evans HM, Howe PRC, Wong RHX. Effects of Resveratrol on Cognitive
Performance, Mood and Cerebrovascular Function in Post-Menopausal Women;
A 14-Week Randomised Placebo-Controlled Intervention Trial.Nutrients. 2017;9(1).
37. Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR.
Phytoestrogen supplements for the treatment of hot flashes: the
Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.Jama. 2003;290(2):207-214.
38. Cagnacci A, Arangino S, Renzi A, Zanni AL, Malmusi S, Volpe A.
Kava-Kava administration reduces anxiety in perimenopausal women.Maturitas. 2003;44(2):103-109.
39. Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton
Depression Rating Scale: has the gold standard become a lead weight?Am J Psychiatry. 2004;161(12):2163-2177.
40. Kanda F, Oishi K, Sekiguchi K, et al. Characteristics of depression
in Parkinson’s disease: evaluating with Zung’s Self-Rating Depression
Scale. Parkinsonism & related disorders. 2008;14(1):19-23.
41. Pollock V, Cho DW, Reker D, Volavka J. Profile of Mood States: the
factors and their physiological correlates. The Journal of nervous
and mental disease. 1979;167(10):612-614.
42. Travers C, O’Neill SM, King R, Battistutta D, Khoo SK. Greene
Climacteric Scale: norms in an Australian population in relation to age
and menopausal status. Climacteric : the journal of the
International Menopause Society. 2005;8(1):56-62.
43. Alder E. The Blatt-Kupperman menopausal index: a critique.Maturitas. 1998;29(1):19-24.
44. Bu L, Lephart ED. Soy isoflavones modulate the expression of BAD and
neuron-specific beta III tubulin in male rat brain. Neurosci
Lett. 2005;385(2):153-157.
45. Oxfeldt M, Dalgaard LB, Risikesan J, Johansen FT, Hansen M.
Influence of Fermented Red Clover Extract on Skeletal Muscle in Early
Postmenopausal Women: A Double-Blinded Cross-Over Study.Nutrients. 2020;12(11).
46. Izumi T, Piskula MK, Osawa S, et al. Soy isoflavone aglycones are
absorbed faster and in higher amounts than their glucosides in humans.The Journal of nutrition. 2000;130(7):1695-1699.
47. Kaari C, Haidar MA, Júnior JM, et al. Randomized clinical trial
comparing conjugated equine estrogens and isoflavones in postmenopausal
women: a pilot study. Maturitas. 2006;53(1):49-58.
48. Davis SR, Briganti EM, Chen RQ, Dalais FS, Bailey M, Burger HG. The
effects of Chinese medicinal herbs on postmenopausal vasomotor symptoms
of Australian women. A randomised controlled trial. Med J Aust.2001;174(2):68-71.
49. Mason C, de Dieu Tapsoba J, Duggan C, Wang CY, Alfano CM, McTiernan
A. Eating behaviors and weight loss outcomes in a 12-month randomized
trial of diet and/or exercise intervention in postmenopausal women.The international journal of behavioral nutrition and physical
activity. 2019;16(1):113.
50. Yang K. Evidence-based social science: the origin, development and
prospects. . Libr Inf. 2018(03):1-10.